Last reviewed · How we verify
NCT07160777: SEMDERMA
Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation
trial testing cross-linked hyaluronic acid in Facial Aging in 80 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2025
Quick facts
| Lead sponsor | Semikal Technology |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 November 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- cross-linked hyaluronic acid — full drug profile →
- Mesolifter
Conditions studied
- Facial Aging — all drugs for Facial Aging →
- Skin Rejuvenation — all drugs for Skin Rejuvenation →
- Volume Defects in the Mid-face — all drugs for Volume Defects in the Mid-face →
- Lip Augmentation and Correction of Perioral Rhytids — all drugs for Lip Augmentation and Correction of Perioral Rhytids →
Sponsor
Semikal Technology
Who can join
18 and older, any sex, with Facial Aging or Skin Rejuvenation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to verify safety and performance of Semical dermal fillers according to real-world data.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07160777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of cross-linked hyaluronic acid
Trials testing the same drug.
- NCT07520539 — Adding Effect of Cross-linked Hyaluronic Acid to Microneedling After Coronally Advanced Flap in Isolated RT1 Recession · Phase 1, PHASE2 · not yet recruiting
- NCT06508125 — Cross-linked and Non-cross-linked Hyaluronic Acid in Subdeltoid Bursitis · Phase 4 · not yet recruiting
- NCT07241442 — Cross-linked Hyaluronic Acid in Knee Osteoarthritis · completed
Other recruiting trials for Facial Aging
Currently open trials in the same condition.
- NCT07227883 — Secretome Treatment for Facial Rejuvenation · EARLY_PHASE1 · recruiting
Other Semikal Technology trials
Trials by the same sponsor.
- NCT07160764 — Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion · not yet recruiting
- NCT06141018 — Effectiveness and Safety of Intra-articular SEMICAL GEL-B CROSS Therapy in Knee Osteoarthritis (SEM-ART1) · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07160777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Semikal Technology
- Last refreshed: 8 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07160777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing